These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

52 related articles for article (PubMed ID: 7236372)

  • 1. [Serum kinetics and biotransformation of prostenoglycine in the rat, dog and monkey].
    Zanolo G; Gnemi P; Mondino A; Silvestri S; Segre G
    Boll Chim Farm; 1981 Jan; 120(1):55-67. PubMed ID: 7236372
    [No Abstract]   [Full Text] [Related]  

  • 2. Urinary metabolites of (R),(R)-labetalol.
    Alton KB; Chan TM; Pramanik BN
    Drug Metab Dispos; 1994; 22(6):866-72. PubMed ID: 7895603
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics of muraglitazar (BMS-298585), a dual peroxisome proliferator-activated receptors (PPAR) alpha and gamma activator, in mice, rats, dogs, and monkeys.
    Hosagrahara VP; Chandrasena G; Chang SY; Koplowitz B; Hariharan N; Cheng PT; Humphreys WG
    Xenobiotica; 2006 Dec; 36(12):1227-38. PubMed ID: 17162469
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biotransformation of the anti-angiogenic compound SU5416.
    Antonian L; Zhang H; Yang C; Wagner G; Shawver LK; Shet M; Ogilvie B; Madan A; Parkinson A
    Drug Metab Dispos; 2000 Dec; 28(12):1505-12. PubMed ID: 11095590
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interspecies comparison of in vivo caffeine pharmacokinetics in man, monkey, rabbit, rat, and mouse.
    Bonati M; Latini R; Tognoni G; Young JF; Garattini S
    Drug Metab Rev; 1984-1985; 15(7):1355-83. PubMed ID: 6543526
    [No Abstract]   [Full Text] [Related]  

  • 6. Metabolism of mofarotene in hepatocytes and liver microsomes from different species. Comparison with in vivo data and evaluation of the cytochrome P450 isoenzymes involved in human biotransformation.
    Valles B; Schiller CD; Coassolo P; De Sousa G; Wyss R; Jaeck D; Viger-Chougnet A; Rahmani R
    Drug Metab Dispos; 1995 Oct; 23(10):1051-7. PubMed ID: 8654192
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preclinical pharmacokinetics and metabolism of 6-(4-(2,5-difluorophenyl)oxazol-5-yl)-3-isopropyl-[1,2,4]-triazolo[4,3-a]pyridine, a novel and selective p38alpha inhibitor: identification of an active metabolite in preclinical species and human liver microsomes.
    Kalgutkar AS; Hatch HL; Kosea F; Nguyen HT; Choo EF; McClure KF; Taylor TJ; Henne KR; Kuperman AV; Dombroski MA; Letavic MA
    Biopharm Drug Dispos; 2006 Nov; 27(8):371-86. PubMed ID: 16944451
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics of triclopyr (3,5,6-trichloro-2-pyridinyloxyacetic acid) in the beagle dog and rhesus monkey: perspective on the reduced capacity of dogs to excrete this organic acid relative to the rat, monkey, and human.
    Timchalk C; Nolan RJ
    Toxicol Appl Pharmacol; 1997 Jun; 144(2):268-78. PubMed ID: 9194410
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The disposition of acyclovir in different species.
    de Miranda P; Krasny HC; Page DA; Elion GB
    J Pharmacol Exp Ther; 1981 Nov; 219(2):309-15. PubMed ID: 7288622
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetic properties of TDP4815 after single intravenous and oral administrations to rat, rabbit, monkey, dog and in vitro drug metabolism.
    Chen Y; Cheng D; Tio C; Kagan N; Eisennagel S; Dasgupta M; Tomczuk B; Bone R; Huebert N
    Biopharm Drug Dispos; 2008 Apr; 29(3):127-38. PubMed ID: 18186144
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comprehensive quantitative and qualitative evaluation of extrapolation of intravenous pharmacokinetic parameters from rat, dog, and monkey to humans. I. Clearance.
    Ward KW; Smith BR
    Drug Metab Dispos; 2004 Jun; 32(6):603-11. PubMed ID: 15155551
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Repeat oral dosing of prasugrel, a novel P2Y12 receptor inhibitor, results in cumulative and potent antiplatelet and antithrombotic activity in several animal species.
    Niitsu Y; Sugidachi A; Ogawa T; Jakubowski JA; Hashimoto M; Isobe T; Otsuguro K; Asai F
    Eur J Pharmacol; 2008 Jan; 579(1-3):276-82. PubMed ID: 17996866
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of interspecies difference in efflux transporters of hepatocytes from dog, rat, monkey and human.
    Li M; Yuan H; Li N; Song G; Zheng Y; Baratta M; Hua F; Thurston A; Wang J; Lai Y
    Eur J Pharm Sci; 2008 Sep; 35(1-2):114-26. PubMed ID: 18639632
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabolism of 5-isopropyl-6-(5-methyl-1,3,4-oxadiazol-2-yl)-N-(2-methyl-1H-pyrrolo[2,3-b]pyridin-5-yl)pyrrolo[2,1-f][1,2,4]triazin-4-amine (BMS-645737): identification of an unusual N-acetylglucosamine conjugate in the cynomolgus monkey.
    Johnson BM; Kamath AV; Leet JE; Liu X; Bhide RS; Tejwani RW; Zhang Y; Qian L; Wei DD; Lombardo LJ; Shu YZ
    Drug Metab Dispos; 2008 Dec; 36(12):2475-83. PubMed ID: 18787055
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Species-specific, P450- and sulfotransferase-mediated novel ring contraction of a naphthyridine-N-oxide compound in cynomolgus monkey.
    Daniels JS; Espina R; Cao K; Yuan H; Lin J; Diamond S; Johnson B; Rodgers J; Prakash S; Unger S; Christ D; Miwa G; Gan LS; Mutlib A
    Chem Res Toxicol; 2007 Nov; 20(11):1709-17. PubMed ID: 17939741
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetic aspect of tritium-labeled glycosaminoglycans (mesoglycan). Their absorption in rat and monkey and tissue distribution in rat.
    Zanolo G; Giachetti C; Mascellani G; Magliocca R; Ferrari G
    Boll Chim Farm; 1984 May; 123(5):223-35. PubMed ID: 6487425
    [No Abstract]   [Full Text] [Related]  

  • 17. 2,4,5,2',4',5'-Hexachlorobiphenyl: distribution, metabolism, and excretion in the dog and the monkey.
    Sipes IG; Slocumb ML; Perry DF; Carter DE
    Toxicol Appl Pharmacol; 1982 Sep; 65(2):264-72. PubMed ID: 6817469
    [No Abstract]   [Full Text] [Related]  

  • 18. Chlorothiophenecarboxamides as P1 surrogates of inhibitors of blood coagulation factor Xa.
    Mederski WW; Cezanne B; van Amsterdam C; Bühring KU; Dorsch D; Gleitz J; März J; Tsaklakidis C
    Bioorg Med Chem Lett; 2004 Dec; 14(23):5817-22. PubMed ID: 15501047
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparisons of phase I and phase II in vitro hepatic enzyme activities of human, dog, rhesus monkey, and cynomolgus monkey.
    Sharer JE; Shipley LA; Vandenbranden MR; Binkley SN; Wrighton SA
    Drug Metab Dispos; 1995 Nov; 23(11):1231-41. PubMed ID: 8591724
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Species differences in metabolism and pharmacokinetics of a sphingosine-1-phosphate receptor agonist in rats and dogs: formation of a unique glutathione adduct in the rat.
    Anari MR; Creighton MD; Ngui JS; Tschirret-Guth RA; Teffera Y; Doss GA; Tang W; Yu NX; Ciccotto SL; Hobra DF; Coleman JB; Vincent SH; Evans DC
    Drug Metab Dispos; 2006 Aug; 34(8):1367-75. PubMed ID: 16698892
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.